SEKISUI XenoTech ensures quality and productivity with the MVS

To meet stringent quality goals for their clients, XenoTech turns to the Artel MVS.

Pharma and biotech companies rely on CROs like SEKISUI XenoTech to give them in vitro drug toxicity data early in the development process. The drug development teams need accurate and reliable toxicity data to make go/no-go decisions on compounds and, thus, reduce the risk of expensive late-stage failures.